Hemophilia

News Hemophilia

• Persistence pays off in solving hemophilia mystery, showing curiosity drives discovery

  An Australian researcher has found the third and final missing piece in the genetic puzzle of an unusual form of hemophilia, more than 20 year after he discovered the first two pieces. Professor Merlin Crossley, of the University of New South Wales, and his international team studied the blood-clott more

• Pro Bono Bio announces the successful development of subcutaneous and long-acting blood factors VIIa, VIII and IX for the treatment of haemophilia

  Pro Bono Bio Group plc  announced the successful conclusion of a series of pre-clinical trials in haemophiliac subjects conducted with the world’s first long acting blood Factors VIIa, VIII and IX capable of subcutaneous administration. The results of these trials are of great importance as these no more

• Biogen Idec and Sobi Initiate Global Clinical Trials of Long-Lasting Hemophilia A and B Product Candidates in Children

  Biogen Idec and Swedish Orphan Biovitrum announced the initiation of two global pediatric clinical trials of the companies' long-lasting recombinant Factor VIII and Factor IX Fc fusion proteins (rFVIIIFc and rFIXFc) in hemophilia A and B.rFVIIIFc and rFIXFc are fully-recombinant clotting factors dev more

Publications Hemophilia

• A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A

  Human genetic variation contributes to differences in susceptibility to HIV-1 infection. To search for novel host resistance factors, we performed a genome-wide association study (GWAS) in hemophilia patients highly exposed to potentially contaminated factor VIII infusions. Individuals with hemop more

• Anti‐inflammatory/regulatory cytokine microenvironment mediated by IL‐4 and IL‐10 coordinates the immune response in hemophilia A patients infected chronically with Hepatitis C ...

  Abstract In the past decades patients with hemophilia were infected commonly by hepatitis C virus (HCV) and a significant number of patients are infected chronically. Focusing on the role of the immune system for controlling and or maintaining HCV infection, the leukocyte and cytokine profiles o more

• The clot thickens for long-lasting drugs that stop hemophilia short

  Nature Medicine 19, 121 (2013). doi:10.1038/nm0213-121 Author: Alisa Opar more

Market studies Hemophilia

• Hemophilia – Pipeline Review, H1 2012

  Introduction Global Markets Direct’s, 'Hemophilia - Pipeline Review, H1 2012', provides an overview of the Hemophilia therapeutic pipeline. This report provides information on the therapeutic development for Hemophilia, complete with latest updates, and special features on late-stage and discontin more

• Hemophilia A – Pipeline Review, H2 2012

  Introduction Global Markets Direct’s, 'Hemophilia A - Pipeline Review, H2 2012', provides an overview of the Hemophilia A therapeutic pipeline. This report provides information on the therapeutic development for Hemophilia A, complete with latest updates, and special features on late-stage and dis more

• Hemophilia – Pipeline Review, H2 2012

  Introduction Global Markets Direct’s, 'Hemophilia - Pipeline Review, H2 2012', provides an overview of the Hemophilia therapeutic pipeline. This report provides information on the therapeutic development for Hemophilia, complete with latest updates, and special features on late-stage and discontin more

Websites Hemophilia